We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 07, 2020

Pembrolizumab and Nab-Paclitaxel as Salvage Therapy for Platinum-Treated, Locally-Advanced or Metastatic Urothelial Carcinoma

Annals of Oncology

 

Additional Info

Annals of Oncology
Pembrolizumab and Nab-Paclitaxel as Salvage Therapy for Platinum-Treated, Locally-Advanced or Metastatic Urothelial Carcinoma: Interim Results of the Open-Label, Single-Arm, Phase 2 PEANUT Study
Ann. Oncol 2020 Sep 23;[EPub Ahead of Print], P Giannatempo, D Raggi, L Marandino, M Bandini, E Farè, G Calareso, M Colecchia, A Gallina, JS Ross, A Alessi, A Briganti, F Montorsi, R Madison, A Necchi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading